NCT03571633
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03571633
Title Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer (BREASTIMMU02)
Acronym BREASTIMMU02
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Centre Leon Berard
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Institut Sainte Catherine Avignon France Details
CHRU Besançon Besançon 25000 France Details
Centre de Lutte contre le Cancer Jean Perrin Clermont-Ferrand 63000 France Details
Groupe Hospitalier Mutualiste de Grenoble Grenoble 38000 France Details
Centre Leon Berard Lyon France Details
Hopital Prive Jean Mermoz Lyon France Details
Centre Hospitalier Annecy Genevois Pringy France Details
Centre Hospitalier Universitaire de Saint Etienne Saint-Etienne France Details
Clinique Charcot Sainte-Foy-lès-Lyon France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field